
2.19 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 1.15 Today|||52-Week Range 3.87 | +40.38% Year-to-Date |
Verve Therapeutics (VERV) Soars 13.8%: Is Further Upside Left in the Stock? Sep 27 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains? Sep 20 / Zacks.com - Paid Partner Content |
Previous close | 2.28 |
Today’s open | 2.17 |
Day’s range | 2.15 - 2.23 |
Volume | 5,064 |
Average volume (3 months) | 395,889 |
Market cap | $84.6M |
Earnings growth (last year) | -18.33% |
Earnings growth (this year) | +149.25% |
Earnings growth (next 5 years) | +5.10% |
Revenue growth (last year) | -61.32% |
P/E ratio | 2.6 |
Price/Sales | 13.06 |
Price/Book | 23.00 |
Today’s change | Today’s % change | |
---|---|---|
CMRXChimerix Inc | +0.00 | +0.48% |
--Santhera Pharmaceuti... | 0.00 | 0.00% |
CTMXCytomX Therapeutics ... | -0.06 | -4.65% |
CLLSCellectis SA | -0.08 | -5.06% |
Next reporting date | November 8, 2023 |
EPS forecast (this quarter) | -$0.14 |
Annual revenue (last year) | $5.1M |
Annual profit (last year) | -$62.8M |
Net profit margin | -1,233.73% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jersey City, New Jersey |